The impact of Bcl-2 on prognosis in diffuse large B cell lymphoma patients treated with RCHOP was de

来源 :The 35th World Congress of the International Society of Hema | 被引量 : 0次 | 上传用户:tting0226
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous group of neoplasm with different clinical,immunophenotypic,and genetic abnormalities as well as highly variable prognosis.In this study,we analyzed Bcl-2 protein expression by immunohistochemistry (IHC) in 60 patients with de novo DLBCL treated with R-CHOP (rituximab,cyclophosphamide,doxorubicin,vincristine,and prednisone).
其他文献
Background According to the current WHO classification of tumors of the hematopoietic and lymphoid tissues,large granular lymphocytic leukemia (LGLL) may be classified as T-LGLL,chronic lymphoprolifer
会议
Objective Peripheral T-cell lymphomas (PTCLs) represent the most prevalent subtype among T-cell neoplasms and constitute a heterogeneous group of disorders.Prognostic characterization of patients is a
会议
Background Acute lymphoblastic leukemia (ALL) is a heterogeneous disease which requires a risk-stratified approach for treatment.Specific chromosomal translocation within leukemic blasts is one of the
会议
Peripheral T-cell lymphoma (PTCL) comprises a heterogeneous group of mature T cell tumors with poor prognosis;Allogeneic stem-cell transplantation (allo-SCT) may offer a potential way of cure for thes
会议
Objective Primary central nervous system lymphoma (PCNSL),a rare extranodal form of non-Hodgkin lymphoma (NHL),represents all primary intracerebral or intraocular lymphomas,arising exclusively in the
会议
Objective Primary gastrointestinal lymphoma represents the most frequent subtype of extranodal non-Hodgkins lymphoma and is a heterogeneous group of disorders.Methods To better define the prognostic f
会议
Objectives Defective autophagy is involved in the pathogenesis and progression of lymphoma.Autophagic modulators are promising approaches to improve the therapeutic efficiency and clinical outcome of
会议
Objective Exploration of the pathogenesis of B-cell lymphomas,including mantle cell lymphoma (MCL),has led to the development of new therapeutic strategies.We focused on the B-cell receptor (BCR) sign
会议
Purpose The unity of CA125 as a prognostic tumor marker has not been consistent to date in non-Hodgkins lymphoma (NHL).Furthermore,serous cavity effusion is frequently observed with elevated serum CA1
会议
Introduction Diffuse large B-cell lymphomas (DLBCL) are the most common lymphoid neoplasms but rarely with leukemic phase.Few studies had described the clinical characteristics of DLBCL with leukemic
会议